3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
3
OTHER
1
NETWORK
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
11
Genitourinary
5
Endocrine
4
Other
3
Classical hematology
3
Thoracic
2
NET
2
Head & Neck
2
Gastrointestinal
2
Breast
2
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Dermatologic
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1734
Lymphoma
1730
Lymphoma, Non-Hodgkin
1205
Leukemia, Lymphocytic, Chronic, B-Cell
1120
Lymphoma, Follicular
1067
Lymphoma, Large B-Cell, Diffuse
1060
Hodgkin Disease
906
Leukemia
877
Lymphoma, Mantle-Cell
738
Leukemia, Myeloid, Acute
662
Burkitt Lymphoma
604
Multiple Myeloma
556
Lymphoma, B-Cell, Marginal Zone
546
Myelodysplastic Syndromes
507
Recurrence
451
Lymphoma, B-Cell
415
Lymphoma, Large-Cell, Immunoblastic
328
Waldenstrom Macroglobulinemia
323
Lymphoma, T-Cell, Cutaneous
322
Mycosis Fungoides
277
Neoplasms
257
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
249
Myeloproliferative Disorders
249
Neoplasms, Plasma Cell
242
Sezary Syndrome
231
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
221
Lymphoma, Large-Cell, Anaplastic
215
Leukemia, Myeloid, Accelerated Phase
211
Lymphoma, T-Cell, Peripheral
205
Blast Crisis
203
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Parkinson Disease
×
Lymphoid
×
Clear all
NCT06416267
2024-05-16
MBL RiskConseq
University of Haifa
Not yet recruiting
1,500 enrolled